Home / India News / Johnson & Johnson expects human trial of its Covid-19 vaccine by September

Johnson & Johnson expects human trial of its Covid-19 vaccine by September

Through a partnership, the Biomedical Advanced Research and Development Authority (BARDA) and Johnson & Johnson together have committed more than $1 billion of investment to co-fund vaccine research

Premium

A worker sprays disinfectant inside a church during a nationwide lockdown, impose in the wake of coronavirus pandemic, in Kanyakumari

Press Trust of India

2 min read Last Updated : Mar 30 2020 | 9:03 PM IST

Global healthcare major Johnson & Johnson (J&J) on Monday said it expects to start human testing of its COVID-19 vaccine by September 2020 and anticipates that the first batch of vaccine could be available for emergency use authorisation in early 2021.

Through a partnership, the Biomedical Advanced Research and Development Authority (BARDA) and Johnson & Johnson together have committed more than $1 billion of investment to co-fund vaccine research, development, and clinical testing, Johnson & Johnson said in a statement.

ALSO READ: Coronavirus LIVE: Govt says lockdown working; CMs appeal and warn people

J&J's lead vaccine candidate will enter

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in